Many individuals with HIV who are receiving antiretroviral therapy have viral genetic material in the cells of their cerebrospinal fluid, making them more likely to experience memory and concentration problems, according to the results of a new study.
The FDA has granted Fast Track Designation for the development of PH94B (VistaGen Therapeutics), a neuroactive nasal spray for on-demand treatment of social anxiety disorder (SAD).
In addition to handling issues such as depression, post-traumatic stress disorder, suicide screenings, and anxiety, many mental health pharmacists deal with typical metabolic conditions, such as hypertension and diabetes.
Exercise improves psychological, behavioral, neurobiological, and overall health of patients.
Suicide rates in the United States increased in nearly every state between 1999 and 2016. More than half of the states had a more than 30% rise in suicides during that period. In 2016, nearly 45,000 lives were lost to suicide.
Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.
A recent study has revealed that just under half of the US population fears random mass shootings and terrorist attacks.
The Pacific Ketamine Institute is now offering esketamine nasal spray (Spravato, Johnson & Johnson) for the treatment of patients who don't respond well to traditional oral antidepressants. It is a prescription medication to be used alongside an oral antidepressant.1
The FDA has approved Zulresso (brexanolone), from Sage Therapeutics, injection to treat postpartum depression (PPD) in adults.1
NAMI Basics OnDemand is an adaptation of the in-person NAMI Basics, a free, 6-session education program for parents, caregivers, and other family who provide care for adolescents aged 22 years or younger who are experiencing mental health symptoms.
The study aimed to determine the association between antidepressant classes, types, and duration of use during pregnancy and the risk of gestational diabetes.
The National Institute on Aging (NIA) has launched 2 new research centers, the Alzheimer Centers for the Discovery of New Medicines, designed to diversify and strengthen the Alzheimer disease drug development pipeline.
Julie Johnson, Dean of the University of Florida College of Pharmacy, on the ways pharmacogenetics can be utilized for mental health.
Older women with breast cancer who have a concurrent mental health condition are more likely to use opioids and have worse survival outcomes.
Tera Moore, PharmD, explains the importance of full integration for psychiatric pharmacist providers across the full mental health continuum of care.
As medication experts, pharmacists can use their knowledge regarding drug-drug interactions to help providers select more appropriate medications for patients right from the start.
Genomind is expanding its mental health genetic testing services with the addition of Genomind Professional PGx Express, which provides a more focused report and set of services to enhance the preexisting mental health genetic test.
Pharmacy and public health associations have released statements following the recent shootings in California, Texas, and Ohio, and some are discussing what actions they can take to prevent further gun-related injury and death.
Researchers find anticholinergic drugs may cause vascular dementia.
Many health systems are still unaware of the role of a psychiatric pharmacist provider. Tera Moore, PharmD, discusses strategies for increasing awareness.
Continuing education for administration of long-acting injectable antipsychotic medications.
Washington State University College of Pharmacy and Pharmaceutical Studies is teaching students to recognize patients who need intervention to help save lives.
Tera Moore, PharmD, National Program Manager, VA Pharmacy Benefits Management office, explains the benefits of psychiatric pharmacist providers for patients and interprofessional practice.
Tera Moore, PharmD, discusses key strategies for successfully integrating psychiatric pharmacist providers in mental healthcare teams.
Tera Moore, National Program Manager with the VA Pharmacy Benefits Management Clinical Pharmacy Practice Office, discusses the role that psychiatric pharmacist providers play in their patients' mental health management.
